The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice

被引:44
作者
Guo, Yue [1 ,2 ,5 ]
Liu, Yue [3 ]
Zhang, Chengyue [1 ,2 ,5 ]
Su, Zheng-Yuan [4 ]
Li, Wenji [2 ,5 ]
Huang, Mou-Tuan [3 ]
Kong, Ah-Ng [2 ,5 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Grad Program Pharmaceut Sci, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Chem Biol, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ 08854 USA
[4] Chung Yuan Christian Univ, Dept Biosci Technol, Taoyuan 32023, Taiwan
[5] Rutgers State Univ, Ctr Epigen CAM Nat Prod, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
关键词
DNA METHYLATION PROFILES; COLORECTAL-CANCER; EXPERIMENTAL COLITIS; TNF-ALPHA; RISK; DEACETYLASES; CELLS; INFLAMMATION; EXPRESSION; MECHANISMS;
D O I
10.1093/carcin/bgw042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study shows that the preventive effect of aspirin on azoxymethane/dextran sulfate sodium-induced colitis-associated colon cancer involves epigenetic mechanisms. Aspirin inhibits histone deacetylase activity, restores overall histone H3 lysine 27 acetylation (H3K27ac) and reduces H3K27ac enrichment in tumor necrosis factor alpha, inducible nitric oxide synthase and interleukin 6 promoters, probably leading to the suppression of pro-inflammatory genes.Colorectal cancer (CRC) is the third most common cancer worldwide. Chronic inflammation appears to enhance the risk of CRC. Emerging evidence has suggested that epigenetic mechanisms play an important role in CRC. Aspirin [acetylsalicylic acid (ASA)] has been shown to prevent CRC; however, the epigenetic mechanisms of its action remain unknown. This study investigated the protective role of ASA in azoxymethane (AOM)-initiated and dextran sulfate sodium (DSS)-promoted colitis-associated colon cancer (CAC) and examined the epigenetic effects, particularly on histone 3 lysine 27 acetylation (H3K27ac), underlying the preventive effect of ASA. CF-1 mice were fed with AIN-93M diet with or without 0.02% ASA from 1 week prior to AOM initiation until the mice were killed 20 weeks after AOM injection. Our results showed that AOM/DSS + ASA significantly suppressed inflammatory colitis symptoms and tumor multiplicity. AOM/DSS + ASA reduced AOM/DSS-induced protein expression and the activity of histone deacetylases (HDACs) and globally restored H3K27ac. Furthermore, AOM/DSS + ASA inhibited AOM/DSS-induced enrichment of H3K27ac in the promoters of inducible nitric oxide synthase (iNOS), tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) that corresponded to the dramatic suppression of the messenger RNA (mRNA) and protein levels. Surprisingly, no significant changes in the H3K27ac abundance in the prostaglandin-endoperoxide synthase 2 (Cox-2) promoters or in the Cox-2 mRNA and protein expression were observed. Collectively, our results suggest that a potential novel epigenetic mechanism underlies the chemopreventive effects of ASA, and this mechanism attenuates CAC in AOM/DSS-induced CF-1 mice via the inhibition of HDACs and the modification of H3K27ac marks that suppress iNOS, TNF-alpha and IL-6.
引用
收藏
页码:616 / 624
页数:9
相关论文
共 48 条
[1]   Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials [J].
Algra, Annemijn M. ;
Rothwell, Peter M. .
LANCET ONCOLOGY, 2012, 13 (05) :518-527
[2]   DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status [J].
Arai, Eri ;
Kanai, Yae .
EPIGENOMICS, 2010, 2 (03) :467-481
[3]   Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial [J].
Burn, John ;
Gerdes, Anne-Marie ;
Macrae, Finlay ;
Mecklin, Jukka-Pekka ;
Moeslein, Gabriela ;
Olschwang, Sylviane ;
Eccles, Diane ;
Evans, D. Gareth ;
Maher, Eamonn R. ;
Bertario, Lucio ;
Bisgaard, Marie-Luise ;
Dunlop, Malcolm G. ;
Ho, Judy W. C. ;
Hodgson, Shirley V. ;
Lindblom, Annika ;
Lubinski, Jan ;
Morrison, Patrick J. ;
Murday, Victoria ;
Ramesar, Raj ;
Side, Lucy ;
Scott, Rodney J. ;
Thomas, Huw J. W. ;
Vasen, Hans F. ;
Barker, Gail ;
Crawford, Gillian ;
Elliott, Faye ;
Movahedi, Mohammad ;
Pylvanainen, Kirsi ;
Wijnen, Juul T. ;
Fodde, Riccardo ;
Lynch, Henry T. ;
Mathers, John C. ;
Bishop, D. Timothy .
LANCET, 2011, 378 (9809) :2081-2087
[4]   ESTIMATION OF LIVER-TUMOR VOLUME USING DIFFERENT FORMULAS - AN EXPERIMENTAL-STUDY IN RATS [J].
CARLSSON, G ;
GULLBERG, B ;
HAFSTROM, L .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 105 (01) :20-23
[5]   Chromatin Profiling Reveals Regulatory Network Shifts and a Protective Role for Hepatocyte Nuclear Factor 4α during Colitis [J].
Chahar, Sanjay ;
Gandhi, Vishal ;
Yu, Shiyan ;
Desai, Kinjal ;
Lari, Richard Cowper-Sal ;
Kim, Yona ;
Perekatt, Ansu O. ;
Kumar, Namit ;
Thackray, Joshua K. ;
Musolf, Anthony ;
Kumar, Nikhil ;
Hoffman, A. ;
Londono, Douglas ;
Vazquez, Berta N. ;
Serrano, Lourdes ;
Shin, Hyunjin ;
Lupien, Mathieu ;
Gao, Nan ;
Verzi, Michael P. .
MOLECULAR AND CELLULAR BIOLOGY, 2014, 34 (17) :3291-3304
[6]   Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 [J].
Chan, Andrew T. ;
Ogino, Shuji ;
Fuchs, Charles S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (21) :2131-2142
[7]  
De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279
[8]  
Delker DA, 1998, TOXICOL SCI, V45, P66
[9]   Nitric oxide and TNF-α trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice [J].
Erdman, S. E. ;
Rao, V. P. ;
Poutahidis, T. ;
Rogers, A. B. ;
Taylor, C. L. ;
Jackson, E. A. ;
Ge, Z. ;
Lee, C. W. ;
Schauer, D. B. ;
Wogan, G. N. ;
Tannenbaum, S. R. ;
Fox, J. G. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (04) :1027-1032
[10]   Timeline - The history of cancer epigenetics [J].
Feinberg, AP ;
Tycko, B .
NATURE REVIEWS CANCER, 2004, 4 (02) :143-153